EPO Gene

Aliases &
Descriptions
for EPO

Previous GC identifers: GC07P098853 GC07P099916 GC07P099929 GC07P099963

Summaries
for EPO

Gene Wiki entry for EPO (Erythropoietin)

Genomic Location
for EPO

Proteins
for EPO

PDB structures from and Proteopedia :

1BUY (3D)    1CN4 (3D)    1EER (3D)    

	Invitrogen human recombinant proteins for EPO
	Browse Purified and Recombinant Proteins at Millipore
	Sigma-Aldrich Proteins and CompoZr ZFN for EPO
	R&D Systems Recombinant & Natural Proteins for EPO (Erythropoietin)
	Browse recombinant and purified proteins available from Enzo Life Sciences
	Recombinant Proteins from Abcam (EPO)
	Human Recombinant Proteins from Abnova (EPO)

2 Gene Ontology (GO) cellular component terms (links to tree view):

	Browse Antibodies Central at Invitrogen
	Millipore Mono- and Polyclonal Antibodies for the study of EPO
	Sigma-Aldrich Antibodies for EPO
	R&D Systems Antibodies for EPO (Erythropoietin)
	Antibodies from Abcam (EPO), each with their AbpromiseSM
	Monoclonal and Polyclonal Antibodies from Abnova (EPO)
	Novus Biologicals Antibodies for EPO

	Browse Invitrogen for biochemical assays
	Browse Kits and Assays available from Millipore
	R&D Systems Flow Cytometry Kits for EPO (Erythropoietin)         (see all)
	Browse biochemical assays available from Enzo Life Sciences

Protein Domains/
Families
for EPO

4 InterPro domains/families:

IPR012351 4_helix_cytokine_core  IPR019767 EPO/TPO_CS  IPR003013 Erythroptn  IPR001323 EPO_TPO    GeneDecks  EPO for the domains selected above   About GeneDecksing

Graphical View of Domain Structure for InterPro Entry P01588

ProtoNet protein and cluster: P01588

Gene Function
for EPO

Inhib. RNA:		Invitrogen RNAi Products for gene knock-down (EPO)
		Browse for Gene Knock-down Tools from Millipore
		Abnova Chimera RNAi Products for Gene knock-down (EPO)

Clones:		Invitrogen Clones for EPO
		Browse Clones for the Expression of Recombinant Proteins Available from Millipore

6 MGI mutant phenotypes (inferred from 1 allele) (MGI details for Epo):

3 Gene Ontology (GO) molecular function terms (links to tree view):

Pathways & Interactions
for EPO

2 Invitrogen iPath™ Online BioAtlas - Pathways for EPO (Maps provided by GeneGo):

Putative erythropoietin signaling pathway (part 2)  Role of Akt in hypoxia induced HIF1 activation    GeneDecks  EPO for the pathways selected above   About GeneDecksing

3 Millipore Pathways for EPO

G-protein signaling K-RAS regulation pathway  Development EPO-induced Jak-STAT pathway  Development EPO-induced MAPK pathway    GeneDecks  EPO for the pathways selected above   About GeneDecksing

3 Sigma-Aldrich "Your Favorite Gene" Pathways for  EPO  (Your Favorite Gene powered by Ingenuity)

Hypoxia Signaling in the Cardiovascular System  HIF1&alpha  Erythropoietin Signaling    GeneDecks  EPO for the pathways selected above   About GeneDecksing

3 Kegg Pathways  (Kegg details for EPO):

hsa04060 Cytokine-cytokine receptor interaction  hsa04630 Jak-STAT signaling pathway  hsa04640 Hematopoietic cell lineage    GeneDecks  EPO for the pathways selected above   About GeneDecksing

5/14 Gene Ontology (GO) biological process terms (links to tree view) (see all 14 ):

Drugs & Compounds
for EPO

Transcripts
for EPO

Inhib. RNA:		Invitrogen RNAi Products for gene knock-down (EPO)
		Browse for Gene Knock-down Tools from Millipore
		Abnova Chimera RNAi Products for Gene knock-down (EPO)

Applied Biosystems Silencer® siRNAs: 

REFSEQ mRNAs for EPO gene: 

Applied Biosystems TaqMan ® Gene Expression Assays: 

Expression
for EPO

EPO expression in normal and diseased human tissues

 Applied Biosystems TaqMan ® Gene Expression Assays for EPO

¹ / ² / ³

5 probe-sets matching EPO gene

	Affymetrix probe-set	Array	GeneAnnot data			GeneNote data		GeneTide data
			# genes	Sensitivity	Specificity	Correlation	Length	Gb_Accession	Consensus	Uniqueness	Score	Rank
	1023_at2, 3	U95-A	1	0.88	1.00	1.00	1.00	X02158	0.20	1.00	0.72	1
	207257_at2, 3	U133-A	1	1.00	1.00	--	--	NM_000799	0.60	1.00	0.82	1
	217254_s_at2	U133-A	1	1.00	1.00	--	--	--	--	--	--	--
	207257_at2	U133Plus2	1	1.00	1.00	--	--	--	--	--	--	--
	217254_s_at2	U133Plus2	1	1.00	1.00	--	--	--	--	--	--	--

About this table

GNF BioGPS
    About these images
About these images

CGAP SAGE TAG: GGGTCCAAGT

SOURCE GeneReport for Unigene cluster: Hs.2303

Expression variation in blood from EXPOLDB for EPO

UniProtKB/Swiss-Prot: EPO_HUMAN, P01588

Tissue specificity: Produced by kidney or liver of adult mammals and by liver of fetal or neonatal

mammals

Orthologs
for EPO

Paralogs
for EPO

SNPs/Variants
for EPO

Disorders & Mutations
for EPO

UniProtKB/Swiss-Prot: EPO_HUMAN, P01588

Medical News
for EPO

• Anemic Children With Cancer Benefit From Erythropoietin
• China Approves Use, New Dosage, Of rHu Erythropoietin (EPO) In Surgical Patients
• Gene Delivery Success Demonstrated With Erythropoietin
• Study Questions Use of Scarce Blood Resources for Patients With Cancer Related Anaemia
• DG DISPATCH - ASN: Novel Erythropoietin Stimulating Protein Maintains Hemoglobin Concentration, Requires Less Frequent Dosing

Publications
for EPO

• Large-scale sequencing of two regions in human chromosome 7q22: analysis of 650 kb of genomic sequence around the EPO and CUTL1 loci reveals 17 genes. (PubMed id 9799793)^{2, 3, 4} Glockner G....Rosenthal A. (1998)
• Isolation and characterization of genomic and cDNA clones of human erythropoietin. (PubMed id 3838366)^{2, 3, 4} Jacobs K....Fritsch E.F. (1985)
• Gene expression of mutant erythropoietin in hepatocellular carcinoma. (PubMed id 8396923)^{1, 3, 4} Funakoshi A.... Shimizu S. (1993)
• Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. (PubMed id 18458324)^{3, 4} Tong Z....Zhang K. (2008)
• The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)^{3, 4} Gerhard D.S....Malek J. (2004)
• The DNA sequence of human chromosome 7. (PubMed id 12853948)^{3, 4} Hillier L.W.... Wilson R.K. (2003)
• Efficiency of signalling through cytokine receptors depends critically on receptor orientation. (PubMed id 9774108)^{3, 4} Syed R.S.... Stroud R.M. (1998)
• Structures and functional roles of the sugar chains of human erythropoietins. (PubMed id 1820196)^{3, 4} Takeuchi M. and Kobata A. (1991)
• Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. (PubMed id 3346214)^{3, 4} Takeuchi M....Kobata A. (1988)
• Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry. (PubMed id 3219367)^{3, 4} Sasaki H.... Fukuda M. (1988)
• Structural characterization of human erythropoietin. (PubMed id 3949763)^{3, 4} Lai P.H.... Goldwasser E. (1986)
• Cloning and expression of the human erythropoietin gene. (PubMed id 3865178)^{3, 4} Lin F.-K....Goldwasser E. (1985)
• Isolation of human erythropoietin with monoclonal antibodies. (PubMed id 6698989)^{3, 4} Yanagawa S....Goto M. (1984)
• Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). (PubMed id 16286456)^{1, 3} Gross A.W. and Lodish H.F. (2006)
• Erythropoietin and erythropoietin receptor expression in normal and disturbed pregnancy. (PubMed id 18479804)^{1, 3} Toth B....Jeschke U. (2008)
• A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. (PubMed id 17045782)^{1, 3} Um M....Lodish H.F. (2007)
• Functional erythropoietin autocrine loop in melanoma. (PubMed id 15743794)^{1, 3} Kumar S.M....Xu X. (2005)
• [Relationship between tumor necrosis factor alpha, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor alpha on erythropoietin gene expression] (PubMed id 14990112)^{1, 3} Zhai X.W....Lu F.J. (2004)
• Prognostic significance of erythropoietin expression in human endometrial carcinoma. (PubMed id 15160341)^{1, 3} Acs G....Verma A. (2004)
• Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma. (PubMed id 16278379)^{1, 3} Winter S.C....Harris A.L. (2005)
• Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. (PubMed id 15709164)^{1, 3} Dagnon K....Callard P. (2005)
• Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis. (PubMed id 17145806)^{1, 3} Leo C....Hockel M. (2006)
• Expression of erythropoietin and its receptor in neuroblastomas. (PubMed id 17647284)^{1, 3} Sartelet H....Vassal G. (2007)
• Erythropoietin in thyroid cancer. (PubMed id 16699298)^{1, 3} Yates C.M....Francis G.L. (2006)
• Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. (PubMed id 11305874)^{1, 3} Nagai A....Kim S.U. (2001)
• Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells. (PubMed id 17893874)^{1, 3} Jeong J.Y....Sytkowski A.J. (2008)
• Erythropoietin and erythropoietin receptor expression in human prostate cancer. (PubMed id 15467711)^{1, 3} Arcasoy M.O....Haroon Z.A. (2005)
• The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor. (PubMed id 15777837)^{1, 3} Vittori D....Nesse A. (2005)
• Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. (PubMed id 15856028)^{1, 3} Lai S.Y....Grandis J.R. (2005)
• Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas. (PubMed id 15769989)^{1, 3} Vogel T.W....Zhuang Z. (2005)
• Stem cell factor enhances erythropoietin-mediated transactivation of signal transducer and activator of transcription 5 (STAT5) via the PKA/CREB pathway. (PubMed id 12829027)^{1, 3} Boer A.K....Vellenga E. (2003)
• Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis. (PubMed id 12525458)^{1, 3} Matsuzaki S....Okamura K. (2003)
• Evaluation of tumor necrosis factor-alpha and erythropoietin serum levels in B-cell chronic lymphocytic leukemia patients with anemia. (PubMed id 12187026)^{1, 3} Capalbo S....Liso V. (2002)
• Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. (PubMed id 11994541)^{1, 3} Yokomizo R....Okamura K. (2002)
• Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. (PubMed id 19375647)^{1, 3} Stellacci E....Migliaccio A.R. (2009)
• Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. (PubMed id 18332162)^{1, 3} Garcia-Ramirez M....Simo R. (2008)
• Does erythropoietin have a dark side? Epo signaling and cancer cells. (PubMed id 17636183)^{1, 3} Sytkowski A.J. (2007)
• Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. (PubMed id 17540710)^{1, 3} Bodo E....Paus R. (2007)
• Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. (PubMed id 15709172)^{1, 3} Lee Y.S....Zhuang Z. (2005)
• Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator. (PubMed id 14584755)^{1, 3} Eccles T.G....Francis G.L. (2003)
• Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. (PubMed id 18093155)^{1, 3} Liao Z.B....He Z.H. (2008)
• Increased levels of erythropoietin in nipple aspirate fluid and in ductal cells from breast cancer patients. (PubMed id 18219110)^{1, 3} Mannello F....Tonti G.A. (2008)
• Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin. (PubMed id 16909043)^{1, 3} Dunlop E.A....Lappin T.R. (2006)
• Association between nucleated red blood cells in blood and the levels of erythropoietin, interleukin 3, interleukin 6, and interleukin 12p70. (PubMed id 15988318)^{1, 3} Stachon A....Krieg M. (2005)
• Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. (PubMed id 15142852)^{1, 3} Fandrey J. (2004)
• Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. (PubMed id 15205261)^{1, 3} Beleslin-Cokic B.B....Noguchi C.T. (2004)
• Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. (PubMed id 12759237)^{1, 3} Acs G....Verma A. (2003)
• Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide. (PubMed id 10318834)^{1, 3} Middleton S.A....Jolliffe L.K. (1999)
• Amniotic fluid S100B protein and erythropoietin in pregnancies at risk for fetal hypoxia. (PubMed id 19042077)^{1, 3} Loukovaara M....Andersson S. (2009)
• Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. (PubMed id 15671524)^{1, 3} Arcasoy M.O....Raleigh J.A. (2005)
• Brain and cancer: the protective role of erythropoietin. (PubMed id 15389732)^{1, 3} Buemi M....Grasso G. (2005)
• Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. (PubMed id 15347669)^{1, 3} Wang F....Hankinson O. (2004)
• Does angiotensin II modulate erythropoietin production in HepG2 cells? (PubMed id 15627795)^{1, 3} Benohr P....Gleiter C.H. (2004)
• From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway. (PubMed id 12207089)^{1, 3} Ratcliffe P.J. (2002)
• Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. (PubMed id 12239177)^{1, 3} Stolze I....Fandrey J. (2002)
• Erythropoietin production by a hepatic adenoma in a patient with severe erythrocytosis. (PubMed id 19339771)^{1, 3} Vik A....Hansen J.B. (2009)
• Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. (PubMed id 19027957)^{1, 3} Lifshitz L....Neumann D. (2009)
• Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant. (PubMed id 18722069)^{1, 3} Kim H.J....Kim H.J. (2008)
• Acute and chronic exposure to hypoxia alters ventilatory pattern but not minute ventilation of mice overexpressing erythropoietin. (PubMed id 17652365)^{1, 3} Soliz J....Gassmann M. (2007)
• Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells. (PubMed id 17713555)^{1, 3} Prade-Houdellier N....Beyne-Rauzy O. (2007)
• Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO. (PubMed id 16475009)^{1, 3} Kwon D.N....Kim J.H. (2006)
• Erythropoietin production: Molecular mechanisms of the antagonistic actions of cyclic adenosine monophosphate and interleukin-1. (PubMed id 16684536)^{1, 3} Batmunkh C....Hellwig-Burgel T. (2006)
• Vascular endothelial growth factor and its soluble receptor, Flt-1, are not correlated to erythropoietin in diabetics with normal or reduced renal function. (PubMed id 15705187)^{1, 3} Lenz T....Gossmann J. (2005)
• Association between erythropoietin in cord blood of twins and size at birth: does it relate to gestational factors or to factors during labor or delivery? (PubMed id 15718359)^{1, 3} Morley R....Carlin J.B. (2005)
• Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. (PubMed id 15967106)^{1, 3} Mohyeldin A....Verma A. (2005)
• Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. (PubMed id 15240563)^{1, 3} Warnecke C....Eckardt K.U. (2004)
• Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage. (PubMed id 15073510)^{1, 3} Digicaylioglu M....Lipton S.A. (2004)
• Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. (PubMed id 12975460)^{1, 3} Villa P....Ghezzi P. (2003)
• The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells. (PubMed id 14704034)^{1, 3} Paiboonsukwong K....Muta K. (2003)
• NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. (PubMed id 12482504)^{1, 3} Figueroa Y.G....Beckman B.S. (2002)
• Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. (PubMed id 12463751)^{1, 3} Darling R.J....Beals J.M. (2002)
• Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans. (PubMed id 11906322)^{1, 3} Freudenthaler S.M....Gleiter C.H. (2002)
• Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. (PubMed id 11869305)^{1, 3} Bosman D.R....Watkins P.J. (2002)
• Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. (PubMed id 11493922)^{1, 3} Digicaylioglu M. and Lipton S.A. (2001)
• Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. (PubMed id 9722506)^{1, 3} Okajima Y....Matsuzawa Y. (1998)
• TRPC3 activation by erythropoietin is modulated by TRPC6. (PubMed id 19074769)³ Hirschler-Laszkiewicz I....Miller B.A. (2009)
• Elevated erythropoietin mRNA and protein concentrations in the developing human eye. (PubMed id 18356745)³ Patel S....Ohls R.K. (2008)
• Decreased DMT1 and increased ferroportin 1 expression is the mechanisms of reduced iron retention in macrophages by erythropoietin in rats. (PubMed id 18189270)³ Kong W.N....Chang Y.Z. (2008)
• Erythropoietin promotes hepatic regeneration after extended liver resection in rats. (PubMed id 18086112)³ Schmeding M....Neumann U.P. (2008)
• Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype. (PubMed id 17893875)³ Solar P....Sytkowski A.J. (2008)
• Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator? (PubMed id 18922618)³ Prutchi Sagiv S....Neumann D. (2008)
• Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. (PubMed id 18259195)³ Byts N....Siren A.L. (2008)
• Erythropoietin promotes axonal growth in a model of neuronal polarization. (PubMed id 18586515)³ Ransome M.I. and Turnley A.M. (2008)
• Novel red cell indices indicating reduced availability of iron are associated with high erythropoietin concentration and low ph level in the venous cord blood of newborns. (PubMed id 18414140)³ Ervasti M....Punnonen K. (2008)
• TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells. (PubMed id 18276585)³ Tong Q....Miller B.A. (2008)
• A pilot study on cord blood levels of erythropoietin and its relationship to periventricular leukomalacia in preterm infants. (PubMed id 18160550)³ Okumura A....Watanabe K. (2008)
• Production of human erythropoietin by chimeric chickens. (PubMed id 18201556)³ Kodama D....Iijima S. (2008)
• Inverse relationship between serum erythropoietin and blood lead concentrations in Kathmandu tricycle taxi drivers. (PubMed id 16838166)³ Sakata S....Mori I. (2007)
• Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? (PubMed id 17888545)³ Ghezzi S....Comi G.P. (2007)
• Erythropoietin regulations in humans under different environmental and experimental conditions. (PubMed id 17467346)³ Gunga H.C....Schobersberger W. (2007)
• Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism. (PubMed id 17615151)³ Tringali G....Navarra P. (2007)
• Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury. Laboratory investigation. (PubMed id 18074690)³ Grasso G....Iacopino D.G. (2007)
• Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. (PubMed id 17395782)³ Bogdanova A....Vogel J. (2007)
• Novel role of erythropoietin in proliferative diabetic retinopathy. (PubMed id 17481772)³ Takagi H....Murakami T. (2007)
• Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. (PubMed id 17389738)³ Park S.H....Kim Y.L. (2007)
• Suggestive evidence of erythropoietin level abnormality in patients with sporadic and familial cases of the restless legs syndrome. (PubMed id 17984928)³ Kemlink D....Benakova H. (2007)
• Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. (PubMed id 17873970)³ Guneli E....Gokmen N. (2007)
• Erythropoietin enhances angiogenesis in an experimental cyclosporine A-induced nephrotoxicity model in the rat. (PubMed id 17645631)³ Efthimiadou A....Nikolettos N.K. (2007)
• Erythropoietin enhances hippocampal response during memory retrieval in humans. (PubMed id 17360900)³ Miskowiak K....Harmer C.J. (2007)
• Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. (PubMed id 17372034)³ d'Uscio L.V....Katusic Z.S. (2007)

Search for EPO

Genome Databases showing EPO

Other Databases showing EPO

Specialized Databases showing EPO

Services
for EPO